Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11725494.6Aexternal-prioritypatent/EP2579877B1/en
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of CY1115610T1publicationCriticalpatent/CY1115610T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Παρέχονται ενώσεις πυριμιδινυλίου του Τύπου (Ι), όπου το R2 είναι (1) ή φαρμακευτικά αποδεκτά άλατα αυτών, διαδικασία παρασκευής τους, φαρμακευτικές συνθέσεις που τα περιέχουν και χρήση τους στη θεραπεία.Pyrimidinyl compounds of Formula (I) are provided, wherein R2 is (1) or pharmaceutically acceptable salts thereof, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
CY20141100808T2010-06-112014-10-08
MORPHOLINE PYRIMIDINES AND THEIR USE IN THERAPY
CY1115610T1
(en)